Skip Chemo for Older Patients With HER2+ Breast Cancer?

(MedPage Today) -- Adjuvant trastuzumab (Herceptin) failed to demonstrate noninferiority versus trastuzumab plus chemotherapy for older patients with early HER2-positive breast cancer, but trastuzumab alone still warrants consideration for selected...